Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 12

Pharmacogenomics and Personalized Medicine


Archive: Volume 12, 2019

Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov–Smirnov Algorithm

Hu RY, Tian XB, Li B, Luo R, Zhang B, Zhao JM

Pharmacogenomics and Personalized Medicine 2019, 12:369-375

Published Date: 11 December 2019

Pharmacogenomics And Hypertension: Current Insights

Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R

Pharmacogenomics and Personalized Medicine 2019, 12:341-359

Published Date: 22 November 2019

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects

Dorofeeva MN, Shikh EV, Sizova ZM, Tarasenko AV, Denisenko NP, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA, Sychev DA

Pharmacogenomics and Personalized Medicine 2019, 12:329-339

Published Date: 5 November 2019

A Novel Mutation Of The EMD Gene In A Family With Cardiac Conduction Abnormalities And A High Incidence Of Sudden Cardiac Death

Kong D, Zhan Y, Liu C, Hu Y, Zhou Y, Luo J, Gu L, Zhou X, Zhang Z

Pharmacogenomics and Personalized Medicine 2019, 12:319-327

Published Date: 31 October 2019

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare

Giri J, Moyer AM, Bielinski SJ, Caraballo PJ

Pharmacogenomics and Personalized Medicine 2019, 12:305-318

Published Date: 30 October 2019

Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy

Huang M, Zhong J, Lu C, Deng F, Li L, Nong Y, Liang L, Qin H, Deng Y

Pharmacogenomics and Personalized Medicine 2019, 12:297-303

Published Date: 21 October 2019

The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome

Kapedanovska-Nestorovska A, Dimovski AJ, Sterjev Z, Matevska Geskovska N, Suturkova L, Ugurov P, Mitrev Z, Rosalia R

Pharmacogenomics and Personalized Medicine 2019, 12:287-295

Published Date: 21 October 2019

Personalized treatment options for thyroid cancer: current perspectives

Khatami F, Larijani B, Nikfar S, Hasanzad M, Fendereski K, Tavangar SM

Pharmacogenomics and Personalized Medicine 2019, 12:235-245

Published Date: 13 September 2019

Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study

AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Al-Quasmi MN, Aljamal HA

Pharmacogenomics and Personalized Medicine 2019, 12:225-233

Published Date: 4 September 2019

The influence of an IL-4 variable number tandem repeat (VNTR) polymorphism on breast cancer susceptibility

AL-Eitan LN, Rababa'h DM, Alghamdi MA, Khasawneh RH

Pharmacogenomics and Personalized Medicine 2019, 12:201-207

Published Date: 26 August 2019

Toxicogenomic analysis of publicly available transcriptomic data can predict food, drugs, and chemical-induced asthma

Hachim MY, Hachim IY, Elemam NM, Hamoudi RA

Pharmacogenomics and Personalized Medicine 2019, 12:181-199

Published Date: 26 August 2019

A personalized approach to acute myeloid leukemia therapy: current options

Illangeswaran RSS, Das S, Paul DZ, Mathews V, Balasubramanian P

Pharmacogenomics and Personalized Medicine 2019, 12:167-179

Published Date: 2 August 2019

Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia

Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, Na Nakorn C, Sukasem C, Kroll MH

Pharmacogenomics and Personalized Medicine 2019, 12:155-166

Published Date: 6 August 2019

Potential role of pharmacogenomics testing in the setting of enhanced recovery pathways after surgery

Awad H, Ahmed A, Urman RD, Stoicea N, Bergese SD

Pharmacogenomics and Personalized Medicine 2019, 12:145-154

Published Date: 26 July 2019

Update on the pharmacogenomics of pain management

Kaye AD, Garcia AJ, Hall OM, Jeha GM, Cramer KD, Granier AL, Kallurkar A, Cornett EM, Urman RD

Pharmacogenomics and Personalized Medicine 2019, 12:125-143

Published Date: 3 July 2019

Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder

Ai M, Wang J, Chen J, Wang W, Xu X, Gan Y, Li X, Gou X, Cao J, Lv Z, Chen X, Wang H, Ma Q, Kuang L

Pharmacogenomics and Personalized Medicine 2019, 12:97-106

Published Date: 2 July 2019

Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients

AL-Eitan LN, Al-Dalalah IM, Mustafa MM, Alghamdi MA, Elshammari AK, Khreisat WH, Aljamal HA

Pharmacogenomics and Personalized Medicine 2019, 12:87-95

Published Date: 10 June 2019

g-Nomic: a new pharmacogenetics interpretation software

Sabater A, Ciudad CJ, Cendros M, Dobrokhotov D, Sabater-Tobella J

Pharmacogenomics and Personalized Medicine 2019, 12:75-85

Published Date: 29 May 2019

Personalized medicine in breast cancer: pharmacogenomics approaches

Jeibouei S, Akbari ME, Kalbasi A, Aref AR, Ajoudanian M, Rezvani A, Zali H

Pharmacogenomics and Personalized Medicine 2019, 12:59-73

Published Date: 27 May 2019

VKORC1 variants as significant predictors of warfarin dose in Emiratis

Al-Mahayri ZN, Al Jaibeji HS, Saab Y, Soliman K, Al-Gazali L, Patrinos GP, Ali BR

Pharmacogenomics and Personalized Medicine 2019, 12:47-57

Published Date: 17 April 2019

Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors

Nadeau G, Ouimet-Grennan E, Aaron M, Drouin S, Bertout L, Shalmiev A, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M

Pharmacogenomics and Personalized Medicine 2019, 12:33-45

Published Date: 11 April 2019

Population’s perspectives toward biobanks in scientific research: a study from Jordan

Makhlouf H, Alrabadi N, Khabour OF, Alzoubi KH, Al-Delaimy W

Pharmacogenomics and Personalized Medicine 2019, 12:23-32

Published Date: 21 March 2019